Showing 7701-7710 of 20882 results for "".
- Biofrontera Announces Restructuring of Supply Agreement, Reduces Ameluz Transfer Pricinghttps://reachmd.com/news/biofrontera-inc-announces-private-placement-of-up-to-160-million-priced-at-market-per-nasdaq-rules/2462246/Biofrontera has announced a restructuring of agreements with its former parent company, Biofrontera AG, aimed at enhancing long-term profitability. As a result, the transfer price of its leading product, Ameluz, indicated for the treatment of actinic keratosis, will be slashed from 50% to 25% for
- Black People Have the Highest Rates of Death from Heart Disease. Could More Black Cardiologists Help?https://reachmd.com/news/black-people-have-the-highest-rates-of-death-from-heart-disease-could-more-black-cardiologists-help/2457239/For Elston Harris, heart attacks seem to be a generational curse.Several men from his father’s side of the family — including Harris’ uncles — died from heart attacks. Harris, who is 59 and a former college basketball player, almost experienced a similar fate after his own heart
- New Treatment Targets Undruggable Proteins in Neuro Diseaseshttps://reachmd.com/news/new-treatment-targets-undruggable-proteins-in-neuro-diseases/2457226/Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis (ALS). In a new study
- Leading Valley Fever Expert Shares ‘State-of-the-Art’ Knowledge About Fungal Diseasehttps://reachmd.com/news/leading-valley-fever-expert-shares-state-of-the-art-knowledge-about-fungal-disease/2457217/A University of Arizona College of Medicine – Tucson researcher and internationally recognized expert on Valley fever co-authored a review paper, published earlier this month
- Study: GV1001 Reduces Neurodegeneration and Prolongs Lifespan in Mouse Model of Alzheimer's Diseasehttps://reachmd.com/news/study-gv1001-reduces-neurodegeneration-and-prolongs-lifespan-in-mouse-model-of-alzheimers-disease/2457222/by Impact Journals LLC Effect of GV1001 on aging, telomere maintenance, and long-term memory confirmed via bioinformatics analysis. Credit: Aging (2024). DOI: 10.18632/aging.205489 A new re
- Promising Target for CAR T-Cell Therapy Leads to Potent Antitumor Responses Against Cutaneous and Rare Melanomashttps://reachmd.com/news/promising-target-for-car-t-cell-therapy-leads-to-potent-antitumor-responses-against-cutaneous-and-rare-melanomas/2457214/Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.CAR
- UCLA-Led Research Results in FDA Approval of 4-Drug Combination for Frontline Treatment of Metastatic Pancreatic Cancerhttps://reachmd.com/news/ucla-led-research-results-in-fda-approval-of-4-drug-combination-for-frontline-treatment-of-metastatic-pancreatic-cancer/2457215/A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil—together referred to as NALIRIFOX—has been approved by the U.S. Food and Drug Administration (FDA) for the first-line treatmen
- New Genetic Therapy Holds Promise for ALS and Frontotemporal Dementiahttps://reachmd.com/news/new-genetic-therapy-holds-promise-for-als-and-frontotemporal-dementia/2457219/image: Dr Annika van Hummel, Professor Yazi Ke and Professor Lars Ittner from Macquarie University
- U of M Research Advances Potential HIV Cure Strategyhttps://reachmd.com/news/u-of-m-research-advances-potential-hiv-cure-strategy/2457204/MINNEAPOLIS/ST. PAUL (02/14/2024) — Published in the Journal of Infectious Diseases Oxford Academic, research le
- Study Sheds Light on Genetic Variations in Advanced Prostate Cancerhttps://reachmd.com/news/study-sheds-light-on-genetic-variations-in-advanced-prostate-cancer/2457212/Black men with metastatic castration-resistant prostate cancer (mCRPC) had a higher frequency of mismatch repair deficiency (MMRD) or high microsatellite instability (MSI-H) and lower frequency of PTEN and TMPRSS alterations compared with White men, according to a